Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval

Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval

Submitted by admin on April 24, 2013 - 10:19am
Source: 
Seeking Alpha
News Tags: 
Aveo Pharmaceuticals
FDA
tivozanib
GSK
Onyx
Pfizer
renal cell carcinoma
Roche
Headline: 
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval

Do Not Allow Advertisers to Use My Personal information